| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 02/26/2008 | CA2351722C Mast cell-specific signal transducer and cdna thereof |
| 02/26/2008 | CA2315241C Protein rim2 |
| 02/26/2008 | CA2260366C Recombinant n-proteinase, and the production, methods and uses thereof |
| 02/26/2008 | CA2239879C Improved circular site-directed mutagenesis |
| 02/26/2008 | CA2239287C A cascade nucleic acid amplification reaction |
| 02/26/2008 | CA2071010C Modification of starch production |
| 02/25/2008 | CA2586710A1 O-acetyltransferase from neisseria meningitidis, compositions and methods |
| 02/22/2008 | CA2556855A1 Composition and method for enhancing plant transformation and homologous recombination |
| 02/21/2008 | WO2008022265A2 Plant isoflavone and isoflavanone o-methyltransferase genes |
| 02/21/2008 | WO2008022046A2 Dicer substrate rna peptide conjugates and methods for rna therapeutics |
| 02/21/2008 | WO2008021974A1 Production of high tryptophan maize by chloroplast targeted expression of anthranilate synthase |
| 02/21/2008 | WO2008021959A2 Influenza hemagglutinin and neuraminidase variants |
| 02/21/2008 | WO2008021560A2 Dpp-iv resistant gip hybrid polypeptides with selectable properties |
| 02/21/2008 | WO2008021483A2 Prognostic and diagnostic method for disease therapy |
| 02/21/2008 | WO2008021465A2 Method and apparatus for microfluidic injection |
| 02/21/2008 | WO2008021207A2 Zinc finger nuclease-mediated homologous recombination |
| 02/21/2008 | WO2008021149A2 Compositions, devices and methods for treatment of huntington's disease through intracranial delivery of sirna |
| 02/21/2008 | WO2008021136A2 Methods and sequences to suppress primate huntington gene expression in vivo |
| 02/21/2008 | WO2008020960A1 Hybrid promoters |
| 02/21/2008 | WO2008020659A1 Thermophilic l-ribose isomerase and use thereof |
| 02/21/2008 | WO2008020656A1 A dna vaccine for curing chronic hepatitis b and a method of preparing same |
| 02/21/2008 | WO2008020654A2 An l-glutamic acid producing bacterium and a method for producing l-glutamic acid |
| 02/21/2008 | WO2008020653A1 Use of holliday junction-recognizing protein related to cancer |
| 02/21/2008 | WO2008020645A1 Early-maturing transformed plant |
| 02/21/2008 | WO2008020596A2 Treating or preventing cancers over-expressing reg4 or kiaa0101 |
| 02/21/2008 | WO2008020595A1 Novel method for utilization of microbial mutant |
| 02/21/2008 | WO2008020589A1 Nucleic acid strand useful in detecting substance and method thereof |
| 02/21/2008 | WO2008020586A1 Diagnosis and treatment of cancer using anti-desmoglein-3 antibody |
| 02/21/2008 | WO2008020454A1 Resistance of plants to biotic and abiotic stresses by overexpression of protochlorophyllide oxidoreductase c and its isoforms |
| 02/21/2008 | WO2008020308A2 Identification of genes implicated in the virulence of streptococcus agalactiae |
| 02/21/2008 | WO2008020293A2 West nile virus envelope (e) protein antigen and immunoassay |
| 02/21/2008 | WO2008020108A1 Peptides which are immunogenic in relation to the genuses listeria and mycobacterium, antibodies and uses of these |
| 02/21/2008 | WO2008020075A1 Transglutaminase variants with improved specificity |
| 02/21/2008 | WO2008020074A1 Transglutaminase variants with improved specificity |
| 02/21/2008 | WO2008019886A1 Genetic remodeling in bifidobacterium |
| 02/21/2008 | WO2008019861A2 Method for dissolving charged nucleic acid in an organic liquid |
| 02/21/2008 | WO2008019486A1 Nucleic acid modulation of toll-like receptor-mediated immune stimulation |
| 02/21/2008 | WO2008003870A3 Promoter expressed in the dehiscence zone of dry fruits |
| 02/21/2008 | WO2008003776A3 Method for insulating in parallel double and single-stranded nucleic acids and for selectively removing double-stranded nucleic acids from a mixture of double and single-stranded nucleic acids |
| 02/21/2008 | WO2008000881B1 Glycosylated human alpha interferon muteins, method for obtaining them and use |
| 02/21/2008 | WO2008000511A3 Pektin methyltransferases and their applications |
| 02/21/2008 | WO2007149946A3 Composition and methods for expressing reporter molecules in mammalian cells |
| 02/21/2008 | WO2007149570A3 Modulation of protein levels in plants |
| 02/21/2008 | WO2007147868A3 Prevention of muscle atrophy |
| 02/21/2008 | WO2007143538A3 Pike-a enhances infection by myxoma virus |
| 02/21/2008 | WO2007143451A3 Targeted delivery of oncolytic viruses, anti-tumor proteins, plasmids, toxins, hemolysins & chemotherapy |
| 02/21/2008 | WO2007143247A3 Cloning and characterization of l-arabinose transporters from non-conventional yeast |
| 02/21/2008 | WO2007136835A3 Methods and cells for creating functional diversity and uses thereof |
| 02/21/2008 | WO2007134161A3 Compositions and methods for inhibiting expression of the pcsk9 gene |
| 02/21/2008 | WO2007129770A3 Fatty acid synthetase, polynucleotide encoding the same, and uses thereof |
| 02/21/2008 | WO2007128982A3 Compositions and methods for epigenetic modification of nucleic acid sequences in vivo |
| 02/21/2008 | WO2007128496A3 A group of esterases for the enantioselective production of fine and speciality chemicals |
| 02/21/2008 | WO2007116923A3 Sez6l2 oncogene as a therapeutic target and prognostic indicator for lung cancer |
| 02/21/2008 | WO2007103523A3 Antioxidant protein, compositions, and methods of use |
| 02/21/2008 | WO2007038241A8 Modulation of mesenchymal and metastatic cell growth |
| 02/21/2008 | WO2007011941A9 Human anti-b7rp1 neutralizing antibodies |
| 02/21/2008 | WO2006136084A8 Fusion proteins of recombinant sars coronavirus structural proteins, their production and uses |
| 02/21/2008 | WO2006099021B1 Direct reversal of the suppressive function of cd4+ regulatory t cells via toll-like receptor 8 signaling |
| 02/21/2008 | WO2006073458A3 Oligonucleotides comprising a c5-modified pyrimidine |
| 02/21/2008 | WO2006053439A9 Hcv f protein and uses thereof |
| 02/21/2008 | WO2005060641A3 Engineered templates and their use in single primer amplification |
| 02/21/2008 | US20080047040 Stress-inducible plant promoters |
| 02/21/2008 | US20080047039 Transgenic plants comprising expression vector coding heterologous gene sequences which confer disease and herbicide resistance as well as enhanced argronomic and processing characteristics |
| 02/21/2008 | US20080047038 Stress-inducible plant promoters |
| 02/21/2008 | US20080047037 the polypeptides have increased activity and stability at acidic, neutral and alkaline pH and increased temperature; for producing an alcohol, high-maltose or a high-glucose syrup or a mixed syrup, for liquifying a starch-comprising composition |
| 02/21/2008 | US20080047036 Plant transformation method |
| 02/21/2008 | US20080047035 Plasmid which utilizes recombination for efficient genic transfer into host genomes; genetic engineering |
| 02/21/2008 | US20080047034 Nucleic acid molecules encoding novel bacillus thuringiensis Cry2Ae insecticidal proteins, plant cells, plant or seeds comprising the nucleic acid molecules and methods of using same |
| 02/21/2008 | US20080047033 Method for Obtaining the Pathogenic Resistance in Plants |
| 02/21/2008 | US20080047031 Novel FRT recombination sites and methods of use |
| 02/21/2008 | US20080047030 Plant Dwarfing Gene |
| 02/21/2008 | US20080047029 Flowering Induction |
| 02/21/2008 | US20080047028 Plants and seeds of corn variety cv414351 |
| 02/21/2008 | US20080047027 Activation of Nuclear Transfer Embryos |
| 02/21/2008 | US20080047026 by obtaining a population of cells from a sample and sorting the population of cells based on the presence of CD34 and the amount of a selected slow-cycling cell marker expressed by each cell, |
| 02/21/2008 | US20080045703 Short interfering RNA sequences for use in treatment and prevention of cell proliferative, diabetic and nervous system disorders |
| 02/21/2008 | US20080045702 Self-processing plants and plant parts |
| 02/21/2008 | US20080045699 Interleukin-1 Related Gene and Protein |
| 02/21/2008 | US20080045698 Mammalian receptor proteins; related reagents and methods |
| 02/21/2008 | US20080045696 DNA Molecules Encoding L-Glutamate-Gated Chloride Channels From Rhipicephalus Sanguineus |
| 02/21/2008 | US20080045695 Fusion Protein Suitable to be Expressed High Effectively and the Production Method thereof |
| 02/21/2008 | US20080045608 Gene Encoding a Guanine Nucleotide Exchange Factor Binding to Rhoa |
| 02/21/2008 | US20080045474 Method for treatment of invasive cells |
| 02/21/2008 | US20080045473 Compositions and methods for oligonucleotide formulations |
| 02/21/2008 | US20080045472 Targets for human micro rnas in avian influenza virus (h5n1) genome |
| 02/21/2008 | US20080045471 Nucleic Acids For Apoptosis Of Cancer Cells |
| 02/21/2008 | US20080045469 Compositions and Methods for Inhibiting Angiogenesis |
| 02/21/2008 | US20080045457 Ancestral Hepatitis C virus envelope protein sequence |
| 02/21/2008 | US20080045455 RAGE fusion proteins, formulations, and methods of use thereof |
| 02/21/2008 | US20080045454 Polynucleotide encoding a TRIM-cyp polypeptide, compositions thereof, and methods of using same |
| 02/21/2008 | US20080045451 Novel thymidylate synthase mutants |
| 02/21/2008 | US20080044907 Modified cry3a toxins and nucleic acid sequences coding therefor |
| 02/21/2008 | US20080044906 Modified Gene-Silencing Nucleic Acid Molecules and Uses Thereof |
| 02/21/2008 | US20080044905 Promoters functional in plant plastids |
| 02/21/2008 | US20080044904 Glyphosate N-acetyltransferase (GAT) confers glyphosate resistance when expressed in plastids |
| 02/21/2008 | US20080044903 Gene transfer methods |
| 02/21/2008 | US20080044898 Expression vector comprising nucleotide sequences which code plant regulatory sequences; for use in controlling root length, senecense and/or water and nutrient uptake |
| 02/21/2008 | US20080044897 Gene silencing vector and gene silencing method using the same |
| 02/21/2008 | US20080044896 Novel human secreted proteins and polynucleotides encoding the same |
| 02/21/2008 | US20080044886 orthogonal pairs of tRNAs and aminoacyl-tRNA synthetases that can incorporate the coumarin unnatural amino acid L-(7-hydroxycoumarin-4-yl) ethylglycine into proteins produced in eubacterial host cells such as E. coli; producing proteins containing the unnatural amino acid |